Sbi Securities Co., Ltd. Syndax Pharmaceuticals Inc Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 1,500 shares of SNDX stock, worth $21,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500Holding current value
$21,975% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
89.9MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$116 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$85.6 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$73 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$71.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$60.1 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $829M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...